COL6A2 is another gene significantly upregulated in PC9GR cells, and previous reports showed that increased expression of multiple collagen genes, including COL6A2 was associated with drug resistance, tumor metastasis, and poor patient survival in ovarian cancer (57, 58). This evidence concerns the gene COL6A2 and ovarian cancer.